… could match the benefit of levodopa without triggering dyskinesias. Appearing in the MJFF Winter 2011 newsletter,  … of levodopa while avoiding debilitating side effects like dyskinesias.” With funding from the Foundation starting in …

… α-synuclein antibody, which is in Phase 2 trials, using multiple modalities, from antibodies and antisense … grant review committees, and as an ad-hoc reviewer for multiple journals including Neuron and PNAS.  Warren has …

… discovery of a neuroprotective agent for treatment of PD. Multiple mutations within the LRRK2 gene are associated with … is desirable. Project Description: We have identified multiple chemical series that inhibit LRRK2 kinase activity …

… disease, amyotrophic lateral sclerosis (ALS) and multiple sclerosis. The primary objectives of Dr. Nelson's … Dr. Nelson is a scientific advisor to the National Multiple Sclerosis Society and the Amyotrophic Lateral …

… research, patient care, senior officer positions at multiple companies, venture capital partnership, and membership on multiple for-profit and non-profit boards. He is a …

… in movement disorders research. He has led and coordinated multiple clinical trials in Parkinson's disease and has over … therapy in some patients. Dr. O'Sullivan currently oversees multiple research projects on non-motor symptoms in …